Loading...
Last update:  October 15, 2017
12:47 +1GMT

Allergenic Molecule  Ole e 1Homo sapiens  
Epidemiology from Literature
CohortYearCountryTestSubjectsPositive (%)Bibliography
5.2.5 - Source Exposed, Children (Symptoms, IgE)2014SpainIgE5596.92020140618, Cases B
3.1.4 - Source Sensitized (SPT, IgE)2009SpainIgE5392.50020100204, Belver MT
5.2.1 - Source Exposed (Symptoms, SPT)2002SpainSPT13492.500
5.2.1 - Source Exposed (Symptoms, SPT)2008SpainIgE14691.80020081009, Llanes E
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2011SpainIgE9890.80020110304, Garcia BE
5.2.1 - Source Exposed (Symptoms, SPT)2002SpainSPT11990.700
5.2.1 - Source Exposed (Symptoms, SPT)2002SpainIgE11984.000
5.2.1 - Source Exposed (Symptoms, SPT)2013SpainIgE17581.00020130807, Letran A
3.1.4 - Source Sensitized (SPT, IgE)2002SpainIgE7180.000
5.2.1 - Source Exposed (Symptoms, SPT)2001SpainIgE4675.000
1.4 - Respiratory Symptoms, Diagnosed2008SpainIgE78674.05020081010, Barber D
5.4.2 - Source Exposed (Symptoms, SPT, high IgE)1999SpainIgE16471.000
4.1.3 - Heterologous Source Sensitized (SPT)2013ItalyIgE1770.59020131031, Bonura A
3.1.1 - Source Sensitized (SPT)2011ItalyIgE4669.56020110727, Asero R
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2012SpainIgE23366.70020120726, Flores E
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2012SpainIgE5563.60020120726, Pedrosa M
4.1.8 - Heterologous Source Sensitized (SPT, IgE)2012SpainIgE6852.90020120726, Pedrosa M
1.4 - Respiratory Symptoms, Diagnosed2011SpainIgE6848.50020110509, Rodriguez D
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2012ItalyIgE2646.20020120310, Twaroch TE
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2012AustriaIgE5444.40020120310, Twaroch TE
1.11 - Esophagitis, Diagnosed2013SwitzerlandIgE3540.00020130605, Simon D
5.4.2 - Source Exposed (Symptoms, SPT, high IgE)1998SpainIgE (IB)2040.000
1.4 - Respiratory Symptoms, Diagnosed2012FranceIgE12936.40020121204, Caimmi D
1.4 - Respiratory Symptoms, Diagnosed2013SpainIgE18736.40020131016, Feliu A
4.1.5 - Heterologous Source Sensitized (IgE)2009BelgiumIgE2035.00020091121, Ebo DG
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2011SpainIgE8528.20020110304, Garcia BE
1.10 - Any allergy symptom, Diagnosed2010BelgiumIgE8622.09020101214, Gadisseur R
1.10 - Any allergy symptom, Diagnosed2010ItalyIgE1640819.55020100301, Scala E
5.3.1 - Source Exposed (Symptoms, IgE)2012BelgiumIgE9918.18020110223, De Knop KJ
1.11 - Esophagitis, Diagnosed2013NetherlandsIgE7617.10020131020, van Rhijn BD
1.5 - Atopic Dermatitis, Diagnosed2009GermanyIgE2015.00020091005, Ott H
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009BelgiumIgE3713.51020090826, Ebo DG
1.9 - Pollen Allergy2014Czech RepublicIgE8269.30020140606, Panzner P
1.5 - Atopic Dermatitis, Diagnosed2013GermanyIgE1407.86020130111, Ott H
10.1 - Normal Control2009BelgiumIgE263.85020091121, Ebo DG
4.1.2 - Heterologous Source Sensitized (Symptoms, SPT)2011ChinaIgE1001.00020111214, Zheng YW
6.2 - General Population (Adults)2012SwedenIgE3710.81020120528, Patelis A
1.2.1 - Asthma, Diagnosed (Adults)2012SwedenIgE960.00020120528, Patelis A
10.1 - Normal Control2012BelgiumIgE270.00020110223, De Knop KJ
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2009BelgiumIgE220.00020091121, Ebo DG
Developed by
Panservice